Business Context and Reporting Period
This Form 8-K Current Report is filed by InspireMD, Inc. (NSPR) for the reporting period of February 27, 2026. The company is incorporated in Delaware and its common stock trades on The Nasdaq Capital Market.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on a specific corporate governance event.
Material Changes
The primary material change reported is the dismissal of Andrea Tommasoli, the Company's Chief Operating Officer, effective February 27, 2026. Key details regarding this departure include:
- Effective Date: Mr. Tommasoli was released from his duties on April 1, 2026.
- Notice Period: A six-month notice period applies under his Employment Agreement and French labor laws.
- Final Employment Date: Expected to be September 1, 2026.
- Compensation During Notice: Mr. Tommasoli will continue to receive his base salary through the end of the notice period.
- Benefits: Health and provident benefits will continue for a maximum of 12 months under applicable French Law.
- Severance: Entitled to approximately €61,000 gross severance pay plus the balance of accrued and untaken paid leave.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard legal compliance regarding the termination under French law. No unusual items or contingencies were disclosed other than the executive departure.
Investor Verification Checklist
- Verify the impact of the COO departure on the company's operational strategy and subsidiary management (InspireMD Ltd.).
- Confirm the total financial impact of the severance package (€61,000 plus salary and benefits) on the upcoming fiscal quarters.
- Monitor for the appointment of a replacement Chief Operating Officer.
- Review subsequent filings for any changes to the expected final employment date of September 1, 2026.